Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility

Nature Structural and Molecular Biology

Volumn 14, Issue 3, 2007, Pages 215-223

  Xia, Mingxuan ^a   Land, Hartmut ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RAS PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLON; DOWN-REGULATION; ENZYME ACTIVATION; GTPASE-ACTIVATING PROTEINS; HUMANS; MICE; MODELS, BIOLOGICAL; MUTANT PROTEINS; NEOPLASMS; PHOSPHOTYROSINE; PROTEIN TRANSPORT; RAS PROTEINS; RHOA GTP-BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 33847627873     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1208     Document Type: Article

References (64)

1. Land, H., Parada, L.F. & Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
2. Ruley, H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304, 602-606 (1983).
3. Hahn, W.C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999).
4. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57-70 (2000).
5. Ridley, A.J., Paterson, H.F., Noble, M. & Land, H. Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7, 1635-1645 (1988).
6. Hirakawa, T. & Ruley, H.E. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc. Natl. Acad. Sci. USA 85, 1519-1523 (1988).
7. Lloyd, A.C. et al. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11, 663-677 (1997).
8. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16(ink4a). Cell 88, 593-602 (1997).
9. Sewing, A., Wiseman, B., Lloyd, A.C. & Land, H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5588-5597 (1997).
10. Woods, D. et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17, 5598-5611 (1997).
11. Perez-Roger, I., Kim, S.H., Griffiths, B., Sewing, A. & Land, H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18, 5310-5320 (1999).
12. Zhu, J., Woods, D., McMahon, M. & Bishop, J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12, 2997-3007 (1998).
13. Palmero, I., Pantoja, C. & Serrano, M. p19ARF links the tumour suppressor p53 to Ras. Nature 395, 125-126 (1998).
14. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649-659 (1997).
15. Campbell, P.M. & Der, C.J. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin. Cancer Biol. 14, 105-114 (2004).
16. Fearon, E.R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759-767 (1990).
17. Hruban, R.H., Goggins, M., Parsons, J. & Kern, S.E. Progression model for pancreatic cancer. Clin. Cancer Res. 6, 2969-2972 (2000).
18. Wistuba, I.I., Gazdar, A.F. & Minna, J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28, 3-13 (2001).
19. Jackson, E.L. et al. The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res. 65, 10280-10288 (2005).
20. Lewis, B.C. et al. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol. Cell. Biol. 25, 1228-1237 (2005).
21. Burridge, K. & Wennerberg, K. Rho and Rac take center stage. Cell 116, 167-179 (2004).
22. Ridley, A.J. et al. Cell migration: integrating signals from front to back. Science 302, 1704-1709 (2003).
23. Sahai, E. & Marshall, C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142 (2002).
24. Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D. & Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70, 401-410 (1992).
25. Nobes, C.D. & Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62 (1995).
26. Worthylake, R.A., Lemoine, S., Watson, J.M. & Burridge, K. RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol. 154, 147-160 (2001).
27. Ridley, A.J. & Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399 (1992).
28. Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A. & Collard, J.G. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 147, 1009-1022 (1999).
29. Nimnual, A.S., Taylor, L.J. & Bar-Sagi, D. Redox-dependent downregulation of Rho by Rac. Nat. Cell Biol. 5, 236-241 (2003).
30. Wildenberg, G.A. et al. p120-Catenin and p190 RhoGAP regulate cell-Cell adhesion by coordinating antagonism between Rac and Rho. Cell 127, 1027-1039 (2006).
31. Zondag, G.C. et al. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J. Cell Biol. 149, 775-782 (2000).
32. Sahai, E., Olson, M.F. & Marshall, C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20, 755-766 (2001).
33. Takaishi, K. et al. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 9, 273-279 (1994).
34. Yoshioka, K., Matsumura, F., Akedo, H. & Itoh, K. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J. Biol. Chem. 273, 5146-5154 (1998).
35. Vial, E., Sahai, E. & Marshall, C.J. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4, 67-79 (2003).
36. Guo, F. & Zheng, Y. Involvement of Rho family GTPases in p19Arf- and p53-mediated proliferation of primary mouse embryonic fibroblasts. Mol. Cell. Biol. 24, 1426-1438 (2004).
37. Gadea, G., Lapasset, L., Gauthier-Rouviere, C. & Roux, P. Regulation of Cdc42-mediated morphological effects: a novel function for p53. EMBO J. 21, 2373-2382 (2002).
38. D'Abaco, G.M., Whitehead, R.H. & Burgess, A.W. Synergy between Apc min and an activated ras mutation is sufficient to induce colon carcinomas. Mol. Cell. Biol. 16, 884-891 (1996).
39. Whitehead, R.H., VanEeden, P.E., Noble, M.D., Ataliotis, P. & Jat, P.S. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl. Acad. Sci. USA 90, 587-591 (1993).
40. Albini, A. et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245 (1987).
41. Bae, S.N. et al. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res. Treat. 24, 241-255 (1993).
42. Ren, X.D., Kiosses, W.B. & Schwartz, M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18, 578-585 (1999).
43. Sander, E.E. et al. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143, 1385-1398 (1998).
44. Coleman, M.L. et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345 (2001).
45. Feig, L.A. Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol. 1, E25-E27 (1999).
46. Michaelson, D. et al. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152, 111-126 (2001).
47. Noren, N.K., Arthur, W.T. & Burridge, K. Cadherin engagement inhibits RhoA via p190 RhoGAP. J. Biol. Chem. 278, 13615-13618 (2003).
48. Brouns, M.R., Matheson, S.F. & Settleman, J. p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat. Cell Biol. 3, 361-367 (2001).
49. Roof, R.W. et al. Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol. Cell. Biol. 18, 7052-7063 (1998).
50. Hu, K.Q. & Settleman, J. Tandem SH2 binding sites mediate the RasGAP-RhoGAP interaction: a conformational mechanism for SH3 domain regulation. EMBO J. 16, 473-483 (1997).
51. Olive, K.P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (2004).
52. Lang, G.A. et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861-872 (2004).
53. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
54. Schroy, P.C., III et al. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer 76, 201-209 (1995).
55. Burri, N. et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81, 217-229 (2001).
56. Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497-1501 (1998).
57. Hernandez, S.E., Settleman, J. & Koleske, A.J. Adhesion-dependent regulation of p190 RhoGAP in the developing brain by the Abl-related gene tyrosine kinase. Curr. Biol. 14, 691-696 (2004).
58. Chiarugi, P. et al. The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J. Biol. Chem. 275, 4640-4646 (2000).
59. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signaure of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003).
60. van't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
61. Morgenstern, J.P. & Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596 (1990).
62. Brummelkamp, T.R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247 (2002).
63. Nobes, C.D. & Hall, A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235-1244 (1999).
64. Nakazawa, T. et al. p250GAP, a novel brain-enriched GTPase-activating protein for Rho family GTPases, is involved in the N-methyl-d-aspartate receptor signaling. Mol. Biol. Cell 14, 2921-2934 (2003).